MACROGENICS INC — Director's Dealing 2025

Feb 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-02-07

Reporting Person: Peters Jeffrey Stuart (Senior VP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-08	Common Stock	M	9001	—	Acquired	9001	Direct
2025-02-08	Common Stock	F	3475	$2.60	Disposed	5526	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-07	Employee Stock Option (right to buy)	$2.60	A	105000	Acquired	2035-02-07	Common Stock (105000)	Direct
2025-02-07	Restricted Stock Unit	$	A	18000	Acquired		Common Stock (18000)	Direct
2025-02-08	Restricted Stock Unit	$	M	9001	Disposed		Common Stock (9001)	Direct

Footnotes

F1: On February 8, 2024, the reporting person was granted 27,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.

F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.

F3: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.